Lauren Groner

Lauren Groner

Auto-generated profile, based on publicly available information

Lauren Groner

Department of Radiology, Weill Cornell Medicine, New York, New York

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in RadioGraphics
Verified
Journal Article
Closed access
LGLauren K. Groner
Lauren K. Groner
DGDaniel B. Green
Daniel B. Green
SWStacey V. Weisman
Stacey V. Weisman
ALAlan C. Legasto
Alan C. Legasto
DTDennis Toy
Dennis Toy
JEJoanna G. Escalon
Joanna G. Escalon
Recognizing common and rare extra-articular thoracic manifestations of rheumatoid arthritis and understanding their imaging features, risk factors, pathogeneses, and natural history can help radiol... Rheumatoid arthritis (RA) is one of the most common chronic systemic inflammatory diseases and the most common chronic inflammatory arthritis. Classically a progressive symmetric polyarthritis, RA ...

27 August 2018 in Current Treatment Options in Cardiovascular Medicine
Verified
Journal Article
Closed access
PDF file
LGLauren K. Groner
Lauren K. Groner
CLChristopher Lau
Christopher Lau
RDRichard Devereux
Richard Devereux
DGDaniel B. Green
Daniel B. Green

1 November 2021 in RadioGraphics
Verified
Journal Article
Closed access
DGDaniel B. Green
Daniel B. Green
LGLauren K. Groner
Lauren K. Groner
JLJared J. Lee
Jared J. Lee
JSJames Shin
James Shin
JBJordi Broncano
Jordi Broncano
ESEugene Shostak
Eugene Shostak
Interventional pulmonology is an evolving subspecialty of pulmonary medicine that focuses on the diagnosis and treatment of benign and malignant diseases through a range of minimally invasive proce... Interventional pulmonology is a growing field specializing in minimally invasive procedures of the mediastinum, lungs, airways, and pleura. These procedures have both diagnostic and therapeutic ind... Created with BioRender.com

1 November 2020 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
LGLauren K. Groner
Lauren K. Groner
DGDaniel B. Green
Daniel B. Green
HSHarsimran S. Singh
Harsimran S. Singh
QTQuynh A. Truong
Quynh A. Truong

1 December 2020 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
DTDennis Toy
Dennis Toy
SMSyed S. Mahmood
Syed S. Mahmood
JRJessica Rotman
Jessica Rotman
LGLauren K. Groner
Lauren K. Groner
SWStacey Verzosa Weisman
Stacey Verzosa Weisman
QTQuynh A. Truong
Quynh A. Truong
Background Coronavirus disease 2019 (COVID-19) affects vulnerable populations (VP) adversely. Purpose To evaluate overall imaging utilization in vulnerable subgroups (elderly, racial/ethnic minorit...

31 October 2025 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
LCLuchang Cui
Luchang Cui
JLJuhong Lee
Juhong Lee
JMJuliet Miller
Juliet Miller
MTMinmeng Tang
Minmeng Tang
SASajjad Abedian
Sajjad Abedian
YSYiwey Shieh
Yiwey Shieh
Background: The proportion of lung cancers affecting individuals who have never smoked is growing, with these cancers being prone to harbor mutations in the EGFR gene. Little is known about risk factors and prognostic indicators for EGFR-mutant cancers, with current research limited by the scarcity of datasets integrating genomic, clinical, and environmental data. Methods: We created the Meyer Cancer Center Molecularly Enhanced Lung Cancer Database (MCC-MELD), including lung cancer cases from a large catchment area in New York City. We identified cases through linkage to our institution’s cancer registry and a clinician-initiated, manually curated database. We linked all cases to the electronic health record and in-house tumor genomic testing results. We used natural language processing (NLP) to extract unstructured genomic testing results and detailed smoking history. We linked geocoded addresses to detailed area-level measures. Results: MCC-MELD contains 9,573 patients with lung cancer diagnosed from 1988 to 2024, of whom 20% were non-Hispanic Asian, 14% were non-Hispanic Black, and 8% were Hispanic. We identified 1,092 (11.4%) EGFR-mutant cancers, with NLP identifying 397 cases not identified by structured data. NLP showed high accuracy in ascertaining EGFR status (97%) and quantitative smoking history variables (90%–98%). Never smokers made up 16% of the cases in MCC-MELD. Conclusions: MCC-MELD is an NLP-enhanced database containing clinical information, genomic testing results, and linkages to area-level data for patients with lung cancer from a diverse urban setting. Impact: This resource can facilitate studies on lung cancer risk factors, treatment patterns, and outcomes by EGFR and other driver mutation status.